Streptococcus sp. and Staphylococcus aureus isolates from patients with psoriasis possess genes that code for toxins (superantigens): Clinical and therapeutic implications

Immunopharmacology and Immunotoxicology

Volumn 30, Issue 2, 2008, Pages 195-205

  El Ferezli, Jessica ^a   Jenbazian, Lori ^a   Rubeiz, Nelly ^a   Kibbi, Abdul Ghani ^a   Zaynoun, Shukrallah ^a   Abdelnoor, Alexander M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Psoriasis; Staphylococcus aureus; Streptococcus sp.; Superantigens; Toxins

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL TOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; STREPTOCOCCUS PYOGENES EXOTOXIN A; STREPTOCOCCUS PYOGENES EXOTOXIN B; STREPTOCOCCUS PYOGENES EXOTOXIN C; STREPTOLYSIN O; SUPERANTIGEN;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PSORIASIS GUTTATA; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS ENTEROTOXIN A GENE; STAPHYLOCOCCUS ENTEROTOXIN B GENE; STAPHYLOCOCCUS ENTEROTOXIN C GENE; STAPHYLOCOCCUS ENTEROTOXIN D GENE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS PYROGENES EXOTOXIN A GENE; STREPTOCOCCUS PYROGENES EXOTOXIN B GENE; STREPTOCOCCUS PYROGENES EXOTOXIN C GENE; STREPTOLYSIN O GENE;

ADULT; BACTERIAL TOXINS; FEMALE; GENES, BACTERIAL; HUMANS; MALE; PSORIASIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SUPERANTIGENS;

STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP.;

EID: 45849145814     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970801946808     Document Type: Article

References (35)

1. De Rie, M.A.; Goedkoop, A.Y.; Bos, J.D. Overview of psoriasis. Dermatol. Ther. 2004, 17, 341-349.
2. Christophers, E.; Mrowietz, U. Psoriasis. In Fitzpatrick's Dermatology in General Medicine, 6th ed. New York: McGraw-Hill, 2003.
3. Jullien, D.; Baker, J. N. Genetics of psoriasis. J. Eur. Acad. Dermatol. Venereol. 2006, 20(Suppl. 2), 42-51.
4. Liu, Y.; Krueger, J. G.; Bowcock, A. M. Psoriasis: Genetic associations and immune system changes. Genes Immun. 2007, 8(1), 1-12.
5. Nickoloff, B. J. The immunologic and genetic basis of psoriasis. Arch. Dermatol. 1999, 135(9), 1104-1110.
6. Rosenberg, E. W.; Noah, P. W.; Skinner, R. B. Microorganisms and psoriasis. J. Natl. Med. Assoc. 1994, 86, 305-310.
7. Proft, T; Fraser, J. D. Bacterial superantigens. Clin. Exp. Immunol. 2003, 133, 299-306.
8. Baker, M. D.; Acharya, K. R. Superantigens: Structure-function relationships. Int. J. Med. Microbiol. 2004, 293, 529-537.
9. Rosen. F.; Geha, R. Case Studies in Immunology: A Clinical Companion, 5th ed. New York: Garland Publishing, 2008, pp. 157-161.
10. Lewis, H. M.; Baker, B. S.; Bokth, S.; Powles, A. V.; Garioch, J. J.; Valdimarsson, H.; Fry, L. Restricted T-cell receptor V beta usage in the skin of patients with guttate and chronic plaque psoriasis. Br. J. Dermatol. 1993, 129, 514-520.
11. Leung, D. Y.; Traverse, J. B.; Giorno, R.; Norris, D. A.; Skinner, R.; Aelion, J.; Kazemi, L. V.; Kim, M. H.; Trumble, A. E.; Kotb, M. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest. 1995, 96, 2106-2112.
12. Sabat, R.; Philipp, S.; Hoflich, C.; Kreutzer, S.; Wallace, E.; Asadullah, K.; Volk, H-D.; Stery, W.; Wolk, K. Immunopathogensis of psoriasis. Exp. Dermatol. 2007, 16, 779-798.
13. Lee, M. R.; Cooper, A. J. Immunopathogenesis of psoriasis. Aust. J. Dermatol. 2006, 47, 151-159.
14. Nickoloff, B., J.; Wrone-Smith, T. Superantigens, autoantigens, and pathogenic T cells in psoriasis. J. Invest. Dermatol. 1998, 110, 459-460.
15. Santamaria-Babi, L. F. CLA(+) T cells in cutaneous diseases. Eur. J. Dermatol. 2004, 14, 13-18.
16. Bos, J. D. ; De Rie, M. A. ; Teunissen, M. B. ; Piskin, G. Psoriasis: Dysregulation of innate immunity. Br. J. Dermatol. 2005, 152, 1098-1107.
17. Ajib, R.; Janbazian, L.; Rahal, E.; Matar, G. M.; Zaynoun, S.; Kibbi, A-G.; Abdelnoor, A. M. HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus. J. Biomed. Biotechnol. 2005, 4, 310-315.
18. Tyler, S. D.; Johnson, W. M.; Huang, J. C.; Ashton, F. E.; Wang, G.; Low, D.E.; Rozee, K. R.; Streptococcal erythrogenic toxin genes: Detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J. Clin. Microbiol. 1992, 30, 3127-3131.
19. Bayles, K.W.; Iandolo, J. J. Genetic and molecular analysis of the gene encoding staphylococcal enterotoxin D. J. Bacteriol. 1989, 171, 4799-4806.
20. Betley, M. J.; Mekalanos, J. J. 1988. Nucleotide sequence of the type A staphylococcus enterotoxin gene. J. Bacteriol. 1988, 170, 34-41.
21. Ranelli, D. M.; Jones, C.L.; Johns, M. B.; Mussey, G. J.; Khan, S. A. Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 5850-5854.
22. Taneike JB, Nakagawa S, Kojio S, Tamura Y, Ishii S, Kurabayashi T, Tanaka K, Yamamoto T. Characterization of toxic shock syndrome-like exananthematous disease-associated methicillin resistant Staphylococcus aureus derived from an outbreak in a neonatal care unit. NCBI Neucleotide Sequence Viewer: Accession number AB084236, 2002.
23. Bowcock, A. M. The genetics of psoriasis and autoimmunity. Annu. Rev. Genomics Hum. Genet. 2005, 6, 93-122.
24. Gaspari, A. A. Innate and adaptive immunity and the pathophysiology of psoriasis. J. Am. Acad. Dermatol. 2006, 54(3 Suppl 2), S67-S80.
25. Fairweather, D.; Rose, N. Women and autoimmune disease. Emerg. Infect. Dis. 2004, 10, 2005-2011.
26. Abdelnoor, A. M.; Uwaydah, M.; Hammad, G.; Heneine, W. Some aspects of immunity in patients with typhoid fever. Lab. Sci. Bull. 1986, 2, 53-60.
27. Beutler, B.; Jiang, Z.; Georgel, P.; Crozat, K.; Croker, B.; Rutschmann, S.; Du, X.; Hoebe, K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006, 24, 353-389.
28. Alouf, J. E.; Muller-Alouf, H. Staphylococcal and streptococcal superantigens: Molecular, biological and clinical aspects. Int. J. Med. Microbiol. 2003, 292, 429-440.
29. Brouillard, J. N.; Gunther, S.; Varma, A. K.; Gryski, I.; Herfst, C. A.; Rahman, A. K.; Leung, D. Y.; Schlievert, P. M.; Madrenas, J.; Sundberg, E. J.; McCormick, J. K. Crystal structure of the streptococcal superantigen Spel and functional role of a novel loop domain in T cell activation by group V superantigens. J. Mol. Biol. 2007, 367, 925-934.
30. Henderson, C. A.; Highet, A. S. Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections. Br. J. Dermatol. 1988, 118, 559-561.
31. Kagawa, T. F.; Cooney, J. C.; Baker, H. M.; McSweeney, S.; Liu, M.; Gubba, S. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 2235-2240.
32. Nooh, M. M.; Aziz, R. K.; Kotb, M.; Eroshkin, A.; Chuang, W. J.; Proft, T.; Kansal, R. Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J. Biol. Chem. 2006, 281, 35281-35288.
33. Negi, V-S.; Elluru, S.; Siberil, S.; Graff-Dubois, S.; Mouthon, L.; Kazatchkine, M. D.; Lacroix-Desmazes, S.; Bayry, J.; Kaveri, S. V. Intravenous immunoglobulin: An update on the clinical use and mechanisms of action. J. Clin. Immunol. 2007, 27, 233-245.
34. Gurmin V, Mediwake R, Fernando M, Whittaker S, Rustin MH, Beynon HL: Psoriasis: Response to high-dose intravenous immunoglobulin in three patients. Br. J. Dermatol. 2002, 147, 554-557.
35. McMillin, B. D.; Maddern, B. R. A role for tonsillectomy in the treatment of psoriasis? Ear Nose Throat J. 1999, 78, 155-158.